Cronos Group Inc. is a company primarily focused on cannabinoids. In the United States, it develops, promotes, and supplies hemp-derived wellness and beauty products under the Lord Jones and Happy Dance brands, reaching consumers through online sales, traditional retail outlets, and partnerships within the hospitality sector.
Cronos Group stock last closed at $2.86, up 2.88% from the previous day, and has increased 48.96% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.84 percentage points. Cronos Group stock is currently +48.57% from its 52-week low of $1.93, and -16.62% from its 52-week high of $3.43.
As of Jul 1, 2026, there are 373.66M CRON shares outstanding. The market capitalization of CRON is $1.07B. In the last 24 hours, 1.45M CRON shares were traded.
You need a brokerage account to access the NASDAQ market and buy CRON stock.
We believe that eToro is the best online stock brokerage. eToro gives you:
Get $10 towards your share purchase by creating an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've chosen your brokerage, the next step is to fill out some personal details so you can invest in CRON stock today.
Now that you've filled out your info on one of the best stock apps, you can securely and quickly fund your account:
Watch this video walkthrough for more details depositing money into your new investment account.
After you have decided on the best place to buy Cronos Group stock, it's absolutely critical to evaluate their stock prior to buying, so you actually understand the risk and opportunity.
WallStreetZen was designed to help everyday investors do better fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on CRON's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge CRON's true value.
Using relative valuations methods:
You can do additional valuation analysis on CRON's stock here.
Last year, CRON revenue was $159.54M. In the past five year, CRON's revenue has grown by 25.67% per year. This was faster than the Drug Manufacturers - Specialty & Generic industry average of 9.57%.
You can analyze CRON's earnings and revenue performance here.
Over the last year, executives and large shareholders at CRON have sold more shares than they have bought.
Shannon Buggy, Senior Vice President Global Head of People of CRON, was the latest CRON insider to sell. They sold $25,242.25 worth of CRON shares on May 12, 2026.
Dig into more about who owns CRON shares here.
No, Cronos Group doesn't provide an income stream by paying out dividends.
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
You have two primary types of orders:
Click the Open button and your broker will execute your order.
If you need additional info about buying stocks on eToro, click the how to video below:
Now that you own some CRON stock, you'll want to stay up-to-date on your new shares.
Start a watchlist to get notified of the latest news about your CRON stock.
To summarize, here are the 6 steps to buy stock in Cronos Group:
If you require a brokerage account, eToro is our favorite option.
Get Started with eToro TodayIf you would like to track your investment in Cronos Group, add CRON to your watchlist by clicking the button below.